Latest Insider Transactions at Alx Oncology Holdings Inc (ALXO)
This section provides a real-time view of insider transactions for Alx Oncology Holdings Inc (ALXO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ALX ONCOLOGY HOLDINGS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ALX ONCOLOGY HOLDINGS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 05
2022
|
Shelly Pinto Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+14.92%
|
-
|
|
Aug 05
2022
|
Sophia Randolph CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
37,000
+14.1%
|
-
|
|
Feb 07
2022
|
Peter S Garcia CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+27.31%
|
$60,000
$4.45 P/Share
|
|
Feb 03
2022
|
Jaume Pons PRESIDENT & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,154
+2.54%
|
$24,154
$1.45 P/Share
|
|
Jan 28
2022
|
Shelly Pinto Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+49.78%
|
-
|
|
Dec 15
2021
|
Sophia Randolph CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
23,852
+6.14%
|
$23,852
$1.45 P/Share
|
|
Dec 13
2021
|
Lsv Associates, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
48,390
-0.33%
|
$1,306,530
$27.91 P/Share
|
|
Dec 13
2021
|
Jason Lettmann CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect |
325,377
-1.3%
|
$8,785,179
$27.91 P/Share
|
|
Dec 10
2021
|
Lsv Associates, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
26,274
-0.36%
|
$814,494
$31.49 P/Share
|
|
Dec 10
2021
|
Jason Lettmann CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect |
26,274
-0.36%
|
$814,494
$31.49 P/Share
|
|
Dec 09
2021
|
Lsv Associates, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
76,905
-1.02%
|
$2,384,055
$31.96 P/Share
|
|
Dec 09
2021
|
Jason Lettmann CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect |
76,905
-1.02%
|
$2,384,055
$31.96 P/Share
|
|
Dec 08
2021
|
Lsv Associates, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
42,458
-0.82%
|
$1,401,114
$33.51 P/Share
|
|
Dec 08
2021
|
Jason Lettmann CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect |
42,458
-0.82%
|
$1,401,114
$33.51 P/Share
|
|
Nov 22
2021
|
Sophia Randolph CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
14,884
-8.3%
|
$535,824
$36.77 P/Share
|
|
Nov 22
2021
|
Sophia Randolph CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+14.32%
|
$120,000
$4.08 P/Share
|
|
Oct 19
2021
|
Jaume Pons PRESIDENT & CSO |
SELL
Open market or private sale
|
Direct |
33,400
-1.82%
|
$1,803,600
$54.64 P/Share
|
|
Oct 18
2021
|
Peter S Garcia CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,229
-8.94%
|
$404,824
$56.75 P/Share
|
|
Oct 18
2021
|
Peter S Garcia CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,229
+30.39%
|
$28,916
$4.08 P/Share
|
|
Oct 11
2021
|
Sophia Randolph CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,387
-2.38%
|
$450,607
$61.08 P/Share
|
|
Sep 20
2021
|
Jaume Pons PRESIDENT & CSO |
SELL
Open market or private sale
|
Direct |
16,700
-0.88%
|
$1,252,500
$75.03 P/Share
|
|
Sep 17
2021
|
Peter S Garcia CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
11,345
-13.75%
|
$896,255
$79.46 P/Share
|
|
Sep 17
2021
|
Peter S Garcia CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
11,345
+35.43%
|
$45,380
$4.08 P/Share
|
|
Sep 16
2021
|
Peter S Garcia CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,426
-13.26%
|
$114,080
$80.43 P/Share
|
|
Sep 16
2021
|
Peter S Garcia CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,426
+11.7%
|
$5,704
$4.08 P/Share
|
|
Sep 10
2021
|
Sophia Randolph CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,387
-1.52%
|
$568,799
$77.48 P/Share
|
|
Aug 23
2021
|
Peter S Garcia CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
60,000
-19.98%
|
$4,440,000
$74.27 P/Share
|
|
Aug 23
2021
|
Peter S Garcia CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+46.39%
|
$240,000
$4.08 P/Share
|
|
Aug 19
2021
|
Jaume Pons PRESIDENT & CSO |
SELL
Open market or private sale
|
Direct |
16,700
-0.49%
|
$1,052,100
$63.05 P/Share
|
|
Aug 17
2021
|
Peter S Garcia CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-13.07%
|
$670,000
$67.03 P/Share
|
|
Aug 17
2021
|
Peter S Garcia CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+34.09%
|
$40,000
$4.08 P/Share
|
|
Aug 10
2021
|
Sophia Randolph CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,387
-1.45%
|
$472,768
$64.81 P/Share
|
|
Jul 19
2021
|
Jaume Pons PRESIDENT & CSO |
SELL
Open market or private sale
|
Direct |
16,700
-1.1%
|
$901,800
$54.36 P/Share
|
|
Jul 12
2021
|
Sophia Randolph CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,387
-2.07%
|
$406,285
$55.36 P/Share
|
|
Jun 21
2021
|
Jaume Pons PRESIDENT & CSO |
SELL
Open market or private sale
|
Direct |
16,700
-1.59%
|
$968,600
$58.49 P/Share
|
|
Jun 10
2021
|
Sophia Randolph CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,387
-1.34%
|
$443,220
$60.74 P/Share
|
|
May 19
2021
|
Jaume Pons PRESIDENT & CSO |
SELL
Open market or private sale
|
Direct |
16,700
-1.02%
|
$918,500
$55.53 P/Share
|
|
May 10
2021
|
Sophia Randolph CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,387
-0.96%
|
$457,994
$62.65 P/Share
|
|
Apr 19
2021
|
Jaume Pons PRESIDENT & CSO |
SELL
Open market or private sale
|
Direct |
16,700
-0.6%
|
$968,600
$58.5 P/Share
|
|
Apr 12
2021
|
Sophia Randolph CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,387
-0.74%
|
$443,220
$60.52 P/Share
|
|
Mar 25
2021
|
Jaume Pons PRESIDENT & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+1.75%
|
$0
$0.99 P/Share
|
|
Mar 22
2021
|
Jaume Pons PRESIDENT & CSO |
SELL
Open market or private sale
|
Direct |
16,700
-0.42%
|
$1,118,900
$67.21 P/Share
|
|
Mar 22
2021
|
Jaume Pons PRESIDENT & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,700
+2.86%
|
$16,700
$1.91 P/Share
|
|
Mar 10
2021
|
Sophia Randolph CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,387
-0.89%
|
$546,638
$74.9 P/Share
|
|
Jan 28
2021
|
Peter S Garcia CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,128
+40.17%
|
$24,512
$4.08 P/Share
|
|
Jan 26
2021
|
Jaume Pons PRESIDENT & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+1.78%
|
$0
$0.99 P/Share
|
|
Dec 14
2020
|
G. Walmsley Graham Director |
BUY
Open market or private purchase
|
Indirect |
20,000
+1.97%
|
$1,520,000
$76.0 P/Share
|